Safety and efficacy of apixaban and rivaroxaban versus warfarin in real-world atrial fibrillation patients are similar to their randomized trials: insights from GARFIELD-AF registry
27 August 2021 (00:00 - 00:00)
Organised by:
About the speaker
Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))
160 More presentations in this session
Associate Professor T. Mine (Nishinomiya, JP)
Doctor M. Sugitani (Nishinomiya, JP)
Doctor M. Mansour (Beirut, LB)
Access the full session
The Event
ESC Congress 2021 - The Digital Experience
27 August - 30 August 2021
You may be interested in
Congress Session
Congress Presentation
